Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
42.19-0.11 (-0.26%)
At close: 04:00PM EDT
42.11 -0.08 (-0.19%)
After hours: 05:21PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.69B
Enterprise Value 7.21B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)13.62
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 331.39%
S&P500 52-Week Change 326.27%
52 Week High 343.59
52 Week Low 319.59
50-Day Moving Average 342.08
200-Day Moving Average 333.50

Share Statistics

Avg Vol (3 month) 31.34M
Avg Vol (10 day) 3980.27k
Shares Outstanding 5182.2M
Implied Shares Outstanding 6182.67M
Float 877.49M
% Held by Insiders 115.27%
% Held by Institutions 186.26%
Shares Short (Apr 30, 2024) 46.6M
Short Ratio (Apr 30, 2024) 46.07
Short % of Float (Apr 30, 2024) 47.59%
Short % of Shares Outstanding (Apr 30, 2024) 43.62%
Shares Short (prior month Mar 28, 2024) 49.62M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.79%
Return on Equity (ttm)-92.45%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -484.52M
Net Income Avi to Common (ttm)-460.47M
Diluted EPS (ttm)-2.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)846.29M
Total Cash Per Share (mrq)4.64
Total Debt (mrq)482.3M
Total Debt/Equity (mrq)85.44%
Current Ratio (mrq)10.22
Book Value Per Share (mrq)3.10

Cash Flow Statement

Operating Cash Flow (ttm)-367.05M
Levered Free Cash Flow (ttm)-212.07M